NSCLC News

Latest Articles

• Consolidation Crisis: Phase I Lung Cancer Trial Sites Shrink by 44 Percent as Research Clusters in Major U.S. Hubs

  Published: Apr 21, 2026

  Section: Health

  A new study by the LUNGevity Foundation reveals that the number of unique U.S. clinical trial sites for phase I non-small cell lung cancer (NSCLC) dropped significantly between 202...

• Long-Term Clinical Data Reveals Pralsetinib Dramatically Extends Survival for Patients With Advanced RET Fusion Lung Cancer

  Published: Apr 2, 2026

  Section: Medical News

  A 42-month follow-up study of the ARROW clinical trial demonstrates that the targeted therapy pralsetinib increases median survival to 44 months for patients with specific genetic...